Contiero B, Cozzi G, Lora I, Gottardo F
Department of Animal Medicine, Production and Health, University of Padova, Viale dell'Università 16, 35020 Legnaro (Padova), Italy.
Department of Animal Medicine, Production and Health, University of Padova, Viale dell'Università 16, 35020 Legnaro (Padova), Italy.
Animal. 2025 Jul;19(7):101567. doi: 10.1016/j.animal.2025.101567. Epub 2025 Jun 9.
Antimicrobial resistance is a major concern for public health, requiring a collective effort towards reduced antimicrobial use (AMU) across society. Major AMU in dairy cows is addressed to prevent or treat mastitis. The drying-off represents a critical time for AMU as administering antimicrobials to all quarters of all cows (blanket dry cow therapy - BDCT) is still the most adopted strategy in many countries. To reduce AMU, the European Union (EU) has banned BDCT since January 2022, and farmers were challenged to switch to selective dry cow therapy (SDCT) protocols, which entail antimicrobial treatment only to target cows with a higher risk of intramammary infection at dry-off. This study provided an overview of the practices used by Italian dairy farmers to dry off the cows when the new EU Regulation on AMU came into force. The aim was to identify the efforts required for the transition to SDCT and identify targeted actions to facilitate its success that could be applied in countries where BDCT is still allowed. An extensive survey was carried out between January and March 2022 involving 810 dairy herds rearing more than 61 000 cows. The results showed that 67% of the farmers (60% of the cows) have already adopted dry cow treatment protocols that eliminated or significantly reduced the antimicrobial therapy, whereas the remaining part still used BDCT. In SDCT farms, the mean proportion of cows receiving intramammary antimicrobials at dry-off was 43%. The SDCT farms were generally smaller in size than BDCT ones, and many SDCT farmers seemed to pay more attention to a careful management of the cows at drying-off, combining a reduced milking frequency with a change in the feeding regime to lower milk yield. The SDCT farmers most commonly used individual cow somatic cell count data to identify animals that have to receive intramammary antimicrobials at dry-off, and they declared >300 000 cells/ml the most common threshold above which a cow was targeted for antimicrobial treatment. The survey highlighted that the Italian dairy sector had already made efforts to reduce AMU at dry-off when the new EU regulation started. However, about one-third of the surveyed farms still adopted BDCT, and SDCT protocols were not well codified among different farms. Therefore, further refinements of the selection criteria for treatment allocation, supported by specific farmers' education and training, are needed to promote a responsible AMU at the dry-off of dairy cows.
抗菌药物耐药性是公共卫生的一个主要问题,需要全社会共同努力减少抗菌药物的使用(AMU)。奶牛的主要抗菌药物使用是用于预防或治疗乳腺炎。干奶期是抗菌药物使用的关键时期,因为对所有奶牛的所有乳腺进行抗菌药物给药(全群干奶牛治疗 - BDCT)在许多国家仍然是最常用的策略。为了减少抗菌药物的使用,欧盟(EU)自2022年1月起禁止了BDCT,农民们面临着转向选择性干奶牛治疗(SDCT)方案的挑战,该方案仅对干奶期有较高乳房内感染风险的目标奶牛进行抗菌治疗。本研究概述了新的欧盟抗菌药物使用法规生效时,意大利奶农用于奶牛干奶的做法。目的是确定向SDCT过渡所需的努力,并确定有助于其成功实施的针对性行动,这些行动可应用于仍允许使用BDCT的国家。2022年1月至3月期间进行了一项广泛的调查,涉及810个奶牛群,饲养奶牛超过61000头。结果表明,67%的奶农(60%的奶牛)已经采用了消除或显著减少抗菌治疗的干奶牛治疗方案,而其余部分仍在使用BDCT。在采用SDCT的农场中,干奶期接受乳房内抗菌药物治疗的奶牛平均比例为43%。采用SDCT的农场规模通常比采用BDCT的农场小,许多采用SDCT的奶农似乎在干奶期更加注重对奶牛的精心管理,将减少挤奶频率与改变饲养方式相结合以降低产奶量。采用SDCT的奶农最常使用个体奶牛体细胞计数数据来确定干奶期必须接受乳房内抗菌药物治疗的奶牛,他们宣称>300000个细胞/毫升是最常见的阈值,高于该阈值的奶牛将成为抗菌治疗的目标。调查强调,新的欧盟法规出台时,意大利奶牛业已经在努力减少干奶期的抗菌药物使用。然而,约三分之一的被调查农场仍采用BDCT,且不同农场之间SDCT方案并未得到很好的规范。因此,需要在特定的农民教育和培训支持下,进一步完善治疗分配的选择标准,以促进奶牛干奶期抗菌药物的合理使用。